12:00 AM
Aug 20, 2012
 |  BC Week In Review  |  Company News  |  Management Tracks

Medgenics management update

Medgenics Inc. (LSE:MEDU; NYSE-M:MDGN), Vienna, Va.
Business: Gene/Cell...

Read the full 20 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >